BiotechTube
Home/Xilio Therapeutics/Scott Coleman
SC

Scott Coleman

Chief Development Officer

Xilio Therapeutics

Therapeutic Areas

Oncology

Xilio Therapeutics Pipeline

DrugIndicationPhase
XTX101Advanced solid tumorsPhase 1
XTX202Advanced solid tumorsPhase 1

Leadership Team at Xilio Therapeutics

RR
René Russo
President, Chief Executive Officer and Board Member
UB
Uli Bialucha
Chief Scientific Officer
CF
Chris Frankenfield
Chief Financial and Operating Officer
View full Xilio Therapeutics profile